Director, Global Health Economics and Outcomes Research Hematology

Summit, New Jersey, United States
Jun 17, 2019
Required Education
Bachelors Degree
Position Type
Full time
Req #: 1901137
Location: Summit, New Jersey, United States
Job Category: Market Access
Work Location: 86 Morris Avenue 07901
Organization: Market Access/Pricing
Employee Status: Full-time
Job Type: Regular

Come join Celgene's Global Pricing & Market Access organization! In this Health Economics and Outcomes Research (HEOR) role, you will support Celgene's Myeloid and Lymphoma products through developing and executing HEOR strategy for products across lifecycles. You will work closely in partnership with Myeloid and Lymphoma Market Access Leads to support the market access & pricing strategy. This role will also require collaboration internally with clinical development, medical affairs and other cross functional colleagues as well as externally with HEOR experts to build an integrated evidence generation plan for Celgene's Myeloid portfolio to achieve business objectives.

Responsibilities will include, but are not limited to, the following:
  • Develop and execute health economic & outcomes research strategy for Celgene's Myeloid and Lymphoma assets across early development to post launch lifecycle
  • Lead the execution of HEOR studies and data dissemination, including but not limited to systematic literature reviews, burden of illness, real-world studies, economic modeling, patient-reported outcomes, comparative effectiveness studies, etc.
  • Work in partnership with Global Market Access Leads to support Market Access & Pricing strategy and to ensure full alignment in evidence generation plan for Market Access objectives
  • Engage local team and external experts for global HEOR strategy development and research execution to address local market access needs, and support evidence needs for local HTA/payer submission
  • Collaborate with cross-functional teams, e.g. clinical development, medical affairs, regulatory, biostatistics to integrate HEOR plan in overall evidence generation plan
  • Develop and manage Myeloid & Lymphoma HEOR budgetary plan to ensure optimal allocation and prioritization of HEOR resources to support business objectives
Skills/Knowledge/Experience Required:
  • 8+ years' experience in healthcare or bio-pharmaceutical with in-depth understanding of regulatory and payer system in key global markets, evolving Market Access environment and the implications to the evidence needs by external stakeholders
  • Proficient in leading and conducting HEOR projects with hands-on experience in SLR, burden of illness study, retrospective database/registry/chart review real-world studies, cost-effectiveness & budget impact model development, comparative effectiveness methodologies and patient-reported outcomes strategy.
  • Hands-on experience in supporting product launch and achieving reimbursement in hematology/oncology disease states
  • Strong awareness and knowledge of the latest HEOR methodologies and approaches in the marketplace and how they can be employed to advance product value propositions
  • Solid scientific knowledge and ability to evaluate clinical programs and identify evidence gaps
  • Significant knowledge & experience in creating product value proposition and value messages with supporting evidences
  • Can effectively liaise with cross-functional franchise and disease teams as well as Celgene's global, local and regional teams with an efficient and collaborative working style

Skills/Knowledge/Experience Preferred:
  • Experience in local reimbursement submission and payer negotiations preferred

Competencies Required:
  • Displays excellent business acumen, creative and strategic thinking, problem-solving and decision-making abilities
  • Has excellent written, verbal and interpersonal communication skills, with the ability to communicate complex or technical content in a convincing way to non-technical audiences.
  • Has strong influencing/negotiation skills and the ability to work at peer-level with experienced clinical, regulatory and commercial experts
  • Is comfortable working in a rapidly evolving scientific and competitive landscape with a high degree of ambiguity.
  • Ability in prioritizing and managing multiple projects simultaneously and delivering results in a timely manner.


About Us


At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.